Aandelen in “Productie van medische instrumenten”

Aandeel Datum Koers Evolutie
vlag QuidelOrtho Corp. 29/09 10,595 USD
-2,17% 		-2,17%

Nieuws over “Productie van medische instrumenten”

29/09 · BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy · Persbericht

29/09 · BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy · Persbericht

29/09 · Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher · Persbericht

29/09 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments · Persbericht

29/09 · Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 28 09 2026 - (CGWL) · Persbericht

28/09 · Guerbet : H1 2026 Results. · Persbericht

28/09 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments · Persbericht

28/09 · Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 25 09 2026 - (CGWL) · Persbericht

27/09 · Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform · Persbericht

26/09 · Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? · Persbericht

25/09 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments · Persbericht

25/09 · Are ITGR, BZH, SUPN Obtaining Fair Deals for their Shareholders? · Persbericht

25/09 · Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 24 09 2026] - (CGWL) · Persbericht

25/09 · CROSSJECT strengthens its governance for the industrial and commercial deployment phase · Persbericht

25/09 · CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure · Persbericht

24/09 · Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment · Persbericht

24/09 · From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026 · Persbericht

24/09 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments · Persbericht

24/09 · Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging · Persbericht

24/09 · Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 23 09 2026] - (CGWL) · Persbericht

24/09 · LeMaitre Vascular Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Customer Data Is Exposed · Persbericht

Mijn selecties